# Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B

> **NCT05922306** · EARLY_PHASE1 · RECRUITING · sponsor: **Anhui Medical University** · enrollment: 1084 (estimated)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** PEGylated recombinant human interferon alpha-2b injection
- **DRUG:** PEGylated recombinant human interferon alpha-2b injection

## Key facts

- **NCT ID:** NCT05922306
- **Lead sponsor:** Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 1084 (ESTIMATED)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05922306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05922306, "Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05922306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*